1. Home
  2. BNTC vs AREC Comparison

BNTC vs AREC Comparison

Compare BNTC & AREC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • AREC
  • Stock Information
  • Founded
  • BNTC 1995
  • AREC 2013
  • Country
  • BNTC United States
  • AREC United States
  • Employees
  • BNTC N/A
  • AREC N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • AREC Coal Mining
  • Sector
  • BNTC Health Care
  • AREC Energy
  • Exchange
  • BNTC Nasdaq
  • AREC Nasdaq
  • Market Cap
  • BNTC 88.1M
  • AREC 96.8M
  • IPO Year
  • BNTC N/A
  • AREC 2019
  • Fundamental
  • Price
  • BNTC $11.82
  • AREC $1.03
  • Analyst Decision
  • BNTC Buy
  • AREC Strong Buy
  • Analyst Count
  • BNTC 6
  • AREC 3
  • Target Price
  • BNTC $23.83
  • AREC $4.33
  • AVG Volume (30 Days)
  • BNTC 52.1K
  • AREC 313.1K
  • Earning Date
  • BNTC 02-11-2025
  • AREC 11-14-2024
  • Dividend Yield
  • BNTC N/A
  • AREC N/A
  • EPS Growth
  • BNTC N/A
  • AREC N/A
  • EPS
  • BNTC N/A
  • AREC N/A
  • Revenue
  • BNTC N/A
  • AREC $399,962.00
  • Revenue This Year
  • BNTC N/A
  • AREC N/A
  • Revenue Next Year
  • BNTC N/A
  • AREC $3,208.62
  • P/E Ratio
  • BNTC N/A
  • AREC N/A
  • Revenue Growth
  • BNTC N/A
  • AREC N/A
  • 52 Week Low
  • BNTC $2.69
  • AREC $0.41
  • 52 Week High
  • BNTC $13.29
  • AREC $1.78
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 62.51
  • AREC 42.97
  • Support Level
  • BNTC $11.36
  • AREC $1.16
  • Resistance Level
  • BNTC $13.29
  • AREC $1.27
  • Average True Range (ATR)
  • BNTC 0.96
  • AREC 0.08
  • MACD
  • BNTC 0.23
  • AREC -0.02
  • Stochastic Oscillator
  • BNTC 86.05
  • AREC 0.00

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

About AREC American Resources Corporation

American Resources Corp is a next-generation, environmentally, and socially responsible supplier of high-quality raw materials to the new infrastructure market. The firm is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recycled. The firm has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon and rare earth mineral deposits are concentrated. Its business model provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure and electrification markets.

Share on Social Networks: